Adjuvant treatment for high risk melanoma. Where are we now?

The survival rate for stage 3 and 4 melanoma is very poor. In the absence of effective treatments for metastatic disease focus has shifted to the adjuvant setting. While we are now able to identify those who are at high risk of recurrence the role of adjuvant systemic treatment in these individuals...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Anand Sharma (Автор), Tahir Abbas (Автор), Sarah Gwynne (Автор)
Формат:
Опубликовано: Frontiers Media S.A., 2011-12-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

Connect to this object online.

3rd Floor Main Library

Подробно о фондах из 3rd Floor Main Library
Шифр: A1234.567
Копировать 1 Доступно